Details for Patent: 11,661,604
Which drugs does patent 11,661,604 protect, and when does it expire?
Patent 11,661,604 protects RIVFLOZA and is included in one NDA.
This patent has twenty-three patent family members in fourteen countries.
Summary for Patent: 11,661,604
| Title: | Methods and compositions for inhibiting expression of LDHA |
| Abstract: | This disclosure relates to oligonucleotides, compositions and methods useful for reducing LDHA expression, particularly in hepatocytes. |
| Inventor(s): | Bob D. Brown, Henryk T. Dudek, Utsav SAXENA, Natalie PURSELL, Cheng Lai, Weimin Wang, Rachel STORR, Naim Nazef, Boyoung Kim |
| Assignee: | Novo Nordisk Health Care AG |
| Application Number: | US17/022,696 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 11,661,604
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novo | RIVFLOZA | nedosiran sodium | SOLUTION;INJECTION | 215842-001 | Sep 29, 2023 | RX | Yes | Yes | 11,661,604 | ⤷ Start Trial | Y | Y | METHOD OF TREATING PRIMARY HYPEROXALURIA TYPE 1 (PH1) | ⤷ Start Trial | ||
| Novo | RIVFLOZA | nedosiran sodium | SOLUTION;INJECTION | 215842-002 | Sep 29, 2023 | RX | Yes | Yes | 11,661,604 | ⤷ Start Trial | Y | Y | METHOD OF TREATING PRIMARY HYPEROXALURIA TYPE 1 (PH1) | ⤷ Start Trial | ||
| Novo | RIVFLOZA | nedosiran sodium | SOLUTION;INJECTION | 215842-003 | Sep 29, 2023 | RX | Yes | Yes | 11,661,604 | ⤷ Start Trial | Y | Y | METHOD OF TREATING PRIMARY HYPEROXALURIA TYPE 1 (PH1) | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,661,604
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2018346971 | ⤷ Start Trial | |||
| Canada | 3078933 | ⤷ Start Trial | |||
| China | 111448319 | ⤷ Start Trial | |||
| China | 118440940 | ⤷ Start Trial | |||
| China | 118530989 | ⤷ Start Trial | |||
| European Patent Office | 3679141 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
